{"schema_version":"secwatch.filing_event.v1","accession":"0001645113-26-000068","form_type":"8-K","ticker":"NVCR","cik":"0001645113","company_name":"NovoCure Ltd","filed_at":"2026-09-09T11:02:29+00:00","discovered_at":"2026-09-09T11:05:00.512950+00:00","generated_at":"2026-09-09T11:05:04.653409+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"NovoCure director Timothy Scannell retires from board effective Sept 2, 2026","bullets":["Timothy Scannell, a current director, retired from the Board effective September 2, 2026.","His seat was formally vacated pursuant to the Company's Articles of Association.","Retirement after five years of service; no disagreement with Company or management.","No replacement director named in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001645113-26-000068","json":"https://secwatch.observer/filing/0001645113-26-000068.json","markdown":"https://secwatch.observer/filing/0001645113-26-000068.md","text":"https://secwatch.observer/filing/0001645113-26-000068.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1645113/000164511326000068/0001645113-26-000068-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1645113/000164511326000068/nvcr-20260902.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-09T11:05:04.653409+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}